Science & Technology — June 19, 2026

Amyloid beta may trigger Alzheimer’s by disrupting tau protein, not forming plaques. Researchers now suggest the protein interferes with tau, which keeps neurons functioning — pointing to a potential new treatment target beyond the plaques long blamed for the disease.

Science Daily · Read more ↗

Ozempic and Wegovy linked to reduced violent behavior in Rutgers study. GLP-1 drugs appear to weaken the connection between impulsive tendencies and violent behavior, suggesting the medications affect brain function well beyond appetite and weight loss.

Science Daily · Read more ↗

Texas data breach exposed 3 million driver’s licenses and passports. Hackers accessed a Texas government system and stole over 3 million government-issued ID documents in one of the largest state-level identity data breaches on record. Check whether you’re affected.

TechCrunch · Read more ↗

Stem cell therapy kept a severe autoimmune disease in remission for 15 years. Two patients treated for a condition that damages the spinal cord and optic nerve showed no disease recurrence for 15 years after receiving the experimental therapy, researchers reported in Nature.

Nature · Read more ↗